Transfer RNA (tRNA) is a key molecule used for protein synthesis, with multiple points of stress-induced regulation that can include transcription, transcript processing, localization and ribonucleoside base modification. Enzyme-catalyzed modification of tRNA occurs at a number of base and sugar positions and has the potential to influence specific anticodon-codon interactions and regulate translation. Notably, altered tRNA modification has been linked to mitochondrial diseases and cancer progression. In this review specific to Eukaryotic systems, we discuss how recent systems-level analyses using a bioanalytical platform have revealed that there is extensive reprogramming of tRNA modifications in response to cellular stress and during cell cycle progression.
Introduction
The central dogma of molecular biology highlights a unique role for transfer RNA (tRNA), one that bridges nucleobase sequence with amino acid sequence during protein synthesis. tRNA molecules can range in length from 73 to 94 nucleotides, and there are over 25 different enzymatically modified tRNA bases per organism. 2 tRNA plays a vital role in translation, highlighted by the fact that sequence variants, specific modifications and defects in modification systems can be linked to human diseases. [3] [4] [5] [6] Recent evidence provides strong support for the idea that cells use tRNA to dynamically regulate gene expression in response to stress. 1, [7] [8] [9] [10] [11] [12] In this review, we highlight the roles that tRNA modification systems play in disease pathologies and in response to environmental insults. Further, we describe how specific transcripts with a distinct codon bias encode critical stress response proteins that can be translationally regulated by dynamic changes in tRNA wobble base modifications. We also describe how mass spectrometry and computational approaches, combined with molecular analyses, yield data that support the idea that critical stress response transcripts have codon biases that can be translationally linked to specific tRNA modifications. Further, these studies lead us to propose that reprogrammed tRNAs are involved in the selective translation of proteins from families of genes in which there is a second genetic code, in the form of a biased use of degenerate codons.
Our model finds strong parallels in the link between wobble base modifications and the use of the non-standard amino acid selenocysteine. Selenocysteine decoding is unconventional because it does not have a dedicated triplet codon, and instead "recodes" internal UGA stop codons in mRNA. Stop codon recoding depends upon the presence of a selenocysteine insertion sequence (SECIS) in the 3' untranslated region (UTR) of the mRNA transcript as well as accessory factors to promote positioning of tRNA SEC into the ribosome. [13] [14] [15] Importantly tRNA SEC must contain modified uridine wobble bases at position 34 that include 5-methoxycarbonylmethyluridine (mcm 5 U) and 5-methoxycarbonylmethyl-2′-O-methyluridine (mcm 5 Um), which promote optimal anticodon-codon interactions needed to decode selenocysteine-containing proteins. [16] [17] [18] Stop-codon recoding illustrates our model of codon bias regulating translation, as the transcripts that encode the 25 selenoproteins in humans have at least twice as many stop codons as the other ~25,000 open reading frames in the genome. Selenoproteins also encode critical stress response proteins, namely glutathione peroxidases (GPXs) and thioredoxin reductases (TrxRs), 15 with GPXs and TrxRs being vital to the detoxification of reactive oxygen species (ROS), and TrxRs being further implicated in regulating DNA damage responses. Lastly, efficient stop-codon recoding requires specifically modified tRNA wobble bases. Thus, there are established and emerging links between tRNA modifications, codon bias, and translational regulation in stress responses. As we continue to characterize dynamic tRNA modification signatures and classify gene subsets with an inherent codon bias, our future challenge will be to further develop these observations into models of translational regulation that will likely be disease-, stress-, toxicant-and cell-specific. This will require large-scale genomics, proteomics and computational approaches, as discussed in the final section of this review.
tRNA
a) tRNA structure and modification. The regulatory potential for tRNA modifications can be understood in relation to tRNA structure. tRNA is initially transcribed by RNA polymerase III (RNA Pol III) using the canonical adenine (A), uracil (U), cytosine (C) and guanine (G) nucleobases in RNA. tRNA then folds into a four stem clover leaf secondary structure as defined by a D-stem and loop (DSL), T-stem and loop (TSL), anticodon stem and loop (ASL) and aminoacylation stem, and in some cases a fifth stem in the form of a variable loop. 19, 20 The DSL and TSL contain the modified nucleotides dihydrouridine (D) and pseudouridine (ψ), respectively, but highlight the fact that many different tRNA nucleotides can be enzymatically modified posttranscriptionally. There are over 120 known post-transcriptional tRNA modifications that provide structural stability and help in decoding, among many other known and potential functions. 19, 20 The aminoacylation stem contains a single-stranded 5'-CAA-3' tail that is enzymatically charged with specific amino acids, with the associated aminoacyl tRNA synthetase (aaRS) enzymes well described in another review. 21 The ASL contains the has been demonstrated to be required for the survival of some bladder cancer cell lines.
As evidence, knockdown of ALKBH8 in bladder cancer cell models increases apoptosis, and severely limits metastatic potential. 44 Given that ALKBH8-catalyzed mcm 5 U-based modifications are important for ROS detoxification, these finding suggest that some cancer cells may become "addicted" to specific tRNA modifications as a means of adapting to the inherently ROS-rich environment of cancer cells. [44] [45] In theory this could be a hypermodification of tRNA promoting a disease state, but that is speculative at this point and requires analytical studies in bladder cancer systems. Overall, the regulatory control, tumor growth suppression and oncogenic like connections between p53, protein synthesis and tRNA modification systems is further evidence of the important yet complex roles for tRNA and its modifications in cancer pathophysiology.
Considered together, the above described mitochondrial diseases and different cancers demonstrate that defects in tRNA regulation, the integrity of tRNA and modification status are linked to pathological outcomes. We and others have observed that controlled alteration of tRNA modifications in the anticodon can influence codon interactions in ways that affect positive outcomes in terms of normal cell response to environmental changes. 11, 25, 46 We have proposed the idea that stress-induced modifications are partnered with specific degenerate codons in certain transcripts, which appears as a codon bias, with both being used to regulate translation. These concepts will be discussed in further detail in following sections. Importantly, deciphering some of the rules behind this second genetic code is described further below and has lead to insights into regulatory aspects of gene expression. As many diseases are connected to stress-induced changes in signaling, understanding the regulation of tRNA as well as the regulatory potential of tRNA modifications could lead to diagnostic and therapeutic breakthroughs.
Stress-induced regulation of tRNA
The pathway of tRNA biogenesis from gene to precursor tRNA (pre-tRNA) and on to a mature tRNA molecule for use in translation is a complex process that begins with RNA Pol III directed transcription, followed by 5' and 3' primary transcript processing, intron splicing, and, in the case of eukaryotes, export to the cytoplasm for aminoacylation. 
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Conversely, under conditions of stress such as DNA damage and nutrient deprivation, Maf1 remains in a non-phosphorylated form that inhibits RNA Pol IIIdependent transcription.
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Additionally, in human glioblastoma cells, Maf1 can negatively regulate Pol I-(rRNA) and Pol II-(mRNA) dependent transcription, a function that is linked to the transformed state of the cell, and likely evolved to coordinate all aspects of protein expression with the cellular milieu.
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In almost all domains of life, initial pre-tRNA transcripts undergo processing at their 5' and 3' ends before adopting the canonical cloverleaf secondary structure.
Processing at the 5' end involves the removal of a 5' "leader" sequence by an RNase P endonuclease complex, while mature 3' ends are generated by RNase Z-mediated endonuclease activity, combined with other exonuclease activities that remove precursor "trailer" sequences until the proper 3' end is generated; in some cases, the invariant C and/or A terminal nucleotides are added by a tRNA nucleotidyl transferase. 63-64 For most pre-tRNA molecules, 5' end processing precedes 3' end processing, but the temporal nature of this process is not completely understood. 63 In eukaryotes, it may be facilitated by the molecular chaperone protein La, which binds to 3' oligo-U tracks, providing stability to the pre-tRNA molecule, and offering protection to the 3' ends from exonuclease activity. [63] [64] Human La is regulated in a manner similar to that of Maf1 in S.
cerevisiae: under nutrient-rich conditions, La is phosphorylated by a nutrient-sensing kinase, and this phosphorylated form (pLa) binds and stimulates RNase P activity for tRNA biogenesis. 65, 66 Conversely, in various mammalian thymocyte and cancer-derived cells, pLa is dephosphorylated by a protein phosphatase 2A-like activity in cells exposed to various forms of DNA damage as well as the death receptor activator, Fas, 67 representing a mechanism for the suppression of tRNA biogenesis under conditions of stress leading to apoptosis.
Certain subsets of pre-tRNA species also contain introns that typically disrupt the anticodon loop, and these intron sequences are removed by an endonuclease-mediated splicing process. 68 In Eukarya, the splicing endonuclease is comprised of Sen proteins and, although there is no evidence to suggest that these proteins are directly regulated by stress per se, point mutations in several human Sen family members are associated with the neurodegenerative disease, pontocerebellar hypoplasia (e.g., Sen2, Sen34 and Sen54). 69 Considering that neuronal dysfunction is tightly linked to free radical damage, 70, 71 this raises the intriguing possibility that tRNA intron splicing may be influenced by oxidative stress in the brain, as is observed with tRNA modifications in response to oxidative stress in other eukaryotic and vertebrate cell systems. 11, 12, 72, 73 b) tRNA aminoacylation and localization are regulated by reactive oxygen species.
During tRNA aminoacylation, individual amino acids are attached to their associated tRNAs in a process that involves aminoacyl-tRNA synthetase (aaRS)-catalysis together with activation of the amino acid carboxyl group for peptide bond formation. It is important to note that translational fidelity is determined not only by tRNA anticodon recognition of the correct cognate codon, but also by attachment of the correct amino acid to its corresponding tRNA species. This specificity is achieved by the catalytic active site of the aaRS that typically accommodates only one amino acid for each of the appropriate codons, 74 and mischarging events are circumvented by the editing function of the aaRS. However, there are low-fidelity strains of S. cerevisiae that exhibit high levels of mischarged tRNAs, and this mutant-protein phenotype has been suggested to increase survival after stress as a form of "adaptive translation". 75 Furthermore, it was observed that reactive oxygen species (ROS) stress increases the overall abundance of non-methionyl-tRNAs charged with methionine, leading to an overall increase in Metmisincorporated proteins, and serving to increase the ROS detoxification capacity of the cell as a mechanism to protect against oxidative stress-induced damage. 76, 77 tRNA biogenic processing events are highly compartmentalized within the cell, and this compartmentalization can also be affected by cellular stress. After 5'-3' processing in the nucleus, tRNA molecules are transported to the cytoplasm by export proteins belonging to the importin/karyopherin beta superfamily (S. cerevisiae Los1, and vertebrate Xpo-t) where they undergo splicing and aminoacylation in the cytoplasm. At least two DNA damage response (DDR) proteins are linked to the regulation of tRNA molecules within this cellular landscape in S. cerevisiae. The kinases Mec1 and Rad53
can transmit a cytoplasmic localization signal to Los1 leading to the accumulation of unspliced intron-containing tRNAs in the nucleus, effectively coupling the G1 checkpoint response to a decrease in protein synthesis after exposures that cause DNA damage. The connection between tRNA modification systems and surviving cellular stress suggested that Trm1 and Trm4 could regulate critical DNA repair or ROS mitigation systems.
tRNA modifications in the yeast cell cycle and S-phase stress. Changes in tRNA modification patterns have also been noted for physiological programs and after DNA replication stress. Yeast cells cycle through G1, S and G2 phases during normal growth and distinct transcriptional reprogramming has been reported for these phases. The Trm9/mcm 5 U connection to S-phase damage was also shown to be due to the increased translation of stress response transcripts that possess a specific codon bias. DNA replication in S-phase is limited by the available pool of intracellular 2-deoxyribonucleotides (dNTPs), which are formed from their ribonucleotide precursors by the ribonucleotide reductase (RNR) complex, composed of subunits 1 through 4. 98 The activity of the RNR complex is tightly linked to the cell cycle, having a high level of activity during the transition from G1 to S phase when the demand for dNTPs is accordingly high. 9 The broader implication of these Trm9 studies is that tRNA modification-based translational control mechanisms can regulate RNR activity during Sphase damage and that they can be linked to specific codon usage patterns. In addition, they suggest that some tRNA modification and codon combinations can restrict translation. Apart from mcm 5 U, the biological significance of the 14 other tRNA modifications that change when cells enter G1 of G2 is yet to be determined, 9 but some will likely play regulatory roles similar to modified wobble bases.
Modification tunable transcripts (MoTTs)
Although no codon in the genetic code can specify more than one amino acid, the degeneracy of the genetic code means that several codons can specify the same amino acid. Some synonymous codons are used more frequently than others (i.e., optimal codons), a fact that argues for an optimal code for translational efficiency and accuracy. 104 In support of this argument, the biased used of codons has been positively correlated with the number of copies of the associated tRNA gene, the number of copies of the expressed tRNA isoacceptor and gene expression levels. [105] [106] [107] [108] [109] [110] It is now apparent that biased codon usage occurs at another level and represents a second genetic code. is not random; certain gene subsets are enriched for one particular degenerate codon over another. 1, 11, 25 In tables that specify the genetic code, two-fold degenerate codons for one amino acid (i.e., arginine AGA & AGG) are found in a split codon box next to other two-fold degenerate codons that specify a different amino acid (i.e., serine AGC & AGU). The cognate tRNAs for two-fold degenerate codons require modification at the wobble position 34 and position 37 in order to discriminate the correct amino acid, 19, 111 with hypomodification promoting amino acid misincorporation errors (i.e., arginine misincorporation for serine). Identify MoTTs, find tRNA anti-codon, identify and quantify wobble modification.
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